Columbia Trust’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$291K Buy
3,529
+844
+31% +$64.3K 0.13% 116
2023
Q3
$210K Buy
2,685
+90
+3% +$7.53K 0.12% 126
2023
Q2
$229K Buy
+2,595
New +$223K 0.13% 120
2022
Q3
Sell
-2,374
Closed -$213K 137
2022
Q2
$213K Buy
2,374
+15
+0.6% +$1.52K 0.11% 139
2022
Q1
$257K Buy
2,359
+116
+5% +$12.3K 0.12% 133
2021
Q4
$281K Hold
2,243
0.15% 118
2021
Q3
$281K Sell
2,243
-455
-17% -$58.9K 0.15% 118
2021
Q2
$335K Sell
2,698
-723
-21% -$90.8K 0.19% 111
2021
Q1
$403K Sell
3,421
-976
-22% -$114K 0.25% 100
2020
Q4
$515K Buy
+4,397
New +$484K 0.36% 74
2020
Q2
$484K Sell
5,293
-37
-0.7% -$3.55K 0.43% 66
2020
Q1
$480K Sell
5,330
-238
-4% -$25.3K 0.53% 61
2019
Q4
$631K Buy
+5,568
New +$611K 0.56% 61

Other funds holding MDT

Columbia Trust's MDT Position: Q4 2023 in Review

Columbia Trust increased its Medtronic (MDT) stake by 31% in Q4 2023, buying an estimated $64.3K and bringing the position to 3,529 shares worth $291K. The position accounts for 0.13% of the portfolio, ranked #116.

Columbia Trust first reported a position in MDT in Q4 2019 and has held it in 13 quarters since. The position peaked at $631K in Q4 2019. 2,074 funds tracked by Wall St. Rank hold MDT as of Q4 2023.

  • Columbia Trust held 3,529 shares of Medtronic worth $291K as of Q4 2023.
  • Columbia Trust bought 844 Medtronic shares in Q4 2023, an estimated $64.3K.
  • Medtronic made up 0.13% of Columbia Trust's portfolio in Q4 2023, its #116 holding.
  • Columbia Trust first reported a position in Medtronic in Q4 2019 and has held it in 13 quarters since.
  • Columbia Trust's Medtronic position peaked at $631K in Q4 2019.
  • 2,074 funds tracked by Wall St. Rank held Medtronic as of Q4 2023.

Based on Columbia Trust's 13F filing for Q4 2023, filed 17 Jan 2024.